1. Home
  2. BCYC vs MTRX Comparison

BCYC vs MTRX Comparison

Compare BCYC & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • MTRX
  • Stock Information
  • Founded
  • BCYC 2009
  • MTRX 1984
  • Country
  • BCYC United Kingdom
  • MTRX United States
  • Employees
  • BCYC N/A
  • MTRX N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • MTRX Engineering & Construction
  • Sector
  • BCYC Health Care
  • MTRX Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • MTRX Nasdaq
  • Market Cap
  • BCYC 511.4M
  • MTRX 423.1M
  • IPO Year
  • BCYC 2019
  • MTRX 1990
  • Fundamental
  • Price
  • BCYC $7.39
  • MTRX $10.86
  • Analyst Decision
  • BCYC Buy
  • MTRX Strong Buy
  • Analyst Count
  • BCYC 8
  • MTRX 1
  • Target Price
  • BCYC $29.14
  • MTRX $20.00
  • AVG Volume (30 Days)
  • BCYC 438.9K
  • MTRX 240.3K
  • Earning Date
  • BCYC 05-01-2025
  • MTRX 05-07-2025
  • Dividend Yield
  • BCYC N/A
  • MTRX N/A
  • EPS Growth
  • BCYC N/A
  • MTRX N/A
  • EPS
  • BCYC N/A
  • MTRX N/A
  • Revenue
  • BCYC $35,275,000.00
  • MTRX $708,260,000.00
  • Revenue This Year
  • BCYC N/A
  • MTRX $19.64
  • Revenue Next Year
  • BCYC $0.27
  • MTRX $23.51
  • P/E Ratio
  • BCYC N/A
  • MTRX N/A
  • Revenue Growth
  • BCYC 30.76
  • MTRX N/A
  • 52 Week Low
  • BCYC $6.10
  • MTRX $8.61
  • 52 Week High
  • BCYC $28.67
  • MTRX $15.75
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 40.27
  • MTRX 43.16
  • Support Level
  • BCYC $6.10
  • MTRX $10.10
  • Resistance Level
  • BCYC $8.00
  • MTRX $10.90
  • Average True Range (ATR)
  • BCYC 0.61
  • MTRX 0.71
  • MACD
  • BCYC 0.14
  • MTRX -0.00
  • Stochastic Oscillator
  • BCYC 46.07
  • MTRX 45.54

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About MTRX Matrix Service Company

Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.

Share on Social Networks: